Prof. Nico Lachmann studied Biomedicine at Hannover Medical School and Yale School of Medicine, New Haven, CT, USA. He received his PhD from Hannover Medical School, in 2012 and performed his PostDoctoral career at Hannover Medical School, the Max-Plank Institute for Biomedicine Münster (Germany) and Cincinnati Childrens Hospital Medical Center. In 2015, Prof. Lachmann became a group leader at the “REBIRTH Research center for translational and regenerative medicine” and in 2020 Associate Professor in the German Excellent Cluster RESIST at Hannover Medical School. He received numerous awards including the prestigious Eva-Luise and Horst Köhler Research Award as well as an ERC Starting grant.
The group of Prof. Lachmann combines basic knowledge in hematology with translational approaches using immune cells to develop new cell-based therapies. His lab investigates the use of pluripotent stem cells to establish novel blood cell farming technologies to gain a deeper understanding in the onset of congenital diseases and to harness the potential of macrophages for future immunotherapies.